Director/PDMR Shareholding

RNS Number : 7474O

ConvaTec Group PLC

21 May 2018

 

21 May 2018

ConvaTec Group Plc
("ConvaTec" or "the Company")
Director/PDMR Shareholding

The Company has been notified of the following transaction by a Person Discharging Managerial Responsibility ("PDMR") in ordinary shares of 10 pence each in the share capital of the Company ("Shares").

On 17 May 2018 Mr Paul Moraviec, the Chief Executive Officer and a PDMR, acquired 32,791 Shares at £2.27 per share under the terms of the dividend reinvestment plan operated by the Company's registrars for employees holding shares within its Share Plan Account. Mr Moraviec's resulting shareholding is 5,005,300 Shares.

The attached notification, made in accordance with the requirements of the EU Market Abuse Regulation, gives further detail.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Mr Paul Moraviec
2	Reason for the notification
a)	Position/Status	Chief Executive Officer
b)	Initial notification/Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	ConvaTec Group Plc
b)	LEI	213800LS272L4FIDOH92
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 10p each in ConvaTec Group Plc ("Shares") GB00BD3VFW73
b)	Nature of the transaction	Acquisition of Shares under the terms of the dividend reinvestment plan operated by the Company's registrars for employees holding shares within its Share Plan Account
c)	Price(s) and volume(s)	Price(s) £2.2707	Volume(s) 32,791
d)	Aggregated information - Aggregated volume  - Price	32,791 £74,458.52
e)	Date of the transaction	17 May 2018
f)	Place of the transaction	London Stock Exchange, Main Market (XLON)

Enquiries

Media

Bobby Leach, VP Group Corporate Affairs, ConvaTec                        [phone]

Alastair Elwen, Finsbury                                                                       [phone]

Analysts and Investors

John Crosse, VP Investor Relations, ConvaTec                         [phone]

Kirsty Law, Director Investor Relations, ConvaTec                               [phone]

[e-mail]

 ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec's products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com where a copy of this announcement can also be found.

 

END

 

 

DSHLLFELEAILFIT